Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from JJ.

Same-sex couple calls for protest after Washington eatery refuses to cater their wedding

JJ’s owner tells Rayah Calkins and fiancee Lillian Glover that the restaurant ‘stands by one thing only – the word of God’

The Guardian - US

Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review

The Dow and S&P 500 hit record highs as the stock market rally extended its weekly win streak with modest gains.

Investors Business Daily

J&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook

Johnson & Johnson stock rose Tuesday after the company beat Wall Street's third-quarter expectations, but cut its full-year profit forecast.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson Subsidiary Files For Bankruptcy For Third Time

Johnson & Johnson subsidiary files for bankruptcy to settle talc-related cancer lawsuits. Proposed billion settlement faces legal challenges.

Top News

J&J CEO Slams Biden's Drug Pricing Law, Says It Will 'Chill' Innovation

J&J CEO explained that the new drug-price negotiation law threatens development of new drugs, according to Bloomberg.

International Business Times

Johnson & Johnson To Add $1.1 Billion To Proposed Talc Settlement

Johnson & Johnson would be adding $1.1 billion to its talc settlement proposal.

International Business Times

How High Can This Healthcare Stock Soar With Nvidia's Help?

Dividend King J&J can boost its MedTech business with Nvidia’s help.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Johnson & Johnson Acquires V-Wave For $1.7 Billion To Boost Heart Failure Treatment Portfolio‌ ‌

J&J's strategic move aims to strengthen its position in the congestive heart failure market, foreseeing significant growth ahead.‌ ‌

Zenger

CrowdStrike: What's Ahead For Cybersecurity Player In The Wake Of Its Corporate Crisis

After it botched a cybersecurity software update and slammed customers, CrowdStrike stock is paying the price. A crisis management challenge lies ahead.

Investors Business Daily

J&J Gets Support For $6.5B Baby Talc Settlement Amid Third Bankruptcy Bid: Report

The healthcare giant faces lawsuits from 61,000 claimants who allege that asbestos contamination in its talc products led to ovarian and other cancers.

International Business Times

South Africa drops probe of J&J after it agrees to lower price of TB drug and withdraws patent

Medical advocacy groups welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices, after South African authorities opened an investigation into the conglomerate

The Independent UK

J&J Faces New Class Action Suit Seeking Damages And Medical Monitoring For Cancer

Johnson & Johnson is facing another class action suit that seeks medical monitoring for cancer patients resulting from talc use.

International Business Times

Johnson & Johnson To Pay $700 Million As Talc Settlement

Johnson & Johnson has agreed to pay $700 million as settlement for charges filed by 42 states and Washington DC.

International Business Times

Johnson & Johnson to pay $700m to settle claims it misled consumers

Pharmaceutical giant’s payout settles allegations it misled consumers about safety of its talcum-based powder products.

Al Jazeera

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Is there asbestos in your makeup? Why women with cancer are suing big beauty brands

As tens of thousands of lawsuits related to Johnson & Johnson’s Baby Powder flood US courts, many women are coming forward claiming that talc-based makeup gave them asbestos-related mesothelioma. Why is talc still present in almost all cosmetics?

Investors Business Daily

Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review

The stock market suffered significant losses for the week, with ASML and Taiwan Semiconductor slamming the chip sector. Tesla was a big loser.

The Street

Analyst updates Johnson & Johnson stock price target after earnings

This is what could happen next to Johnson & Johnson shares.

Investors Business Daily

Stocks Soar After Robust Jobs Data; AMD, Amazon.com Lead Tech Rally, But Tesla Sinks On This News

Tech stocks outperformed in the stock market today after another strong jobs report. Small caps shrugged off rising bond yields.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Johnson & Johnson Ends The Shockwave Rumor Mill With $13.1 Billion Takeover

Johnson & Johnson snagged Shockwave Medical in a $13.1 billion cardiovascular intervention deal that sent Shockwave stock rising Friday.

Barchart

4 Top Dividend Kings to Earn Passive Income

Dividend Kings are companies with a long history of paying and increasing shareholder dividends, which signals strong financial health for investors looking to build a steady stream of passive income.

International Business Times

20 Highest-Grossing Biotech Stocks: Giants Driving Innovation and Growth

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

The Guardian - UK

The Guardian view on India-UK trade talks: don’t make it harder for the health service

Editorial: Britain is pushing for patent changes that could increase the cost of Indian generic drugs, diverting more of the NHS budget to big pharma

Investors Business Daily

Dow Jones Stocks: From 3M To Intel, A Big Earnings Week For Blue Chips

Eight Dow Jones stock report earnings this week. Several, including Verizon and 3M, are in buy zones or near buy points.

Barchart

2 Dividend Kings Yielding Around 3% to Grab Now

High yields aren't the only reason to buy shares of dividend-paying stocks. For investors seeking quality dividend stocks for passive income, here's a look at two companies with long track records of raising shareholder payouts.

Investors Business Daily

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot'

Cancer-focused biotech companies Ambrx and Harpoon snapped up a pair of takeover deals. AMAM stock and HARP stock soared.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.